The karyotypic pattern at different stages of tumor development may provide information on tumor progression but few data are available regarding human solid tumors. Cytogenetic analysis was performed on the primary tumor and four lung metastases of a synovial sarcoma, and the primary tumor, two consecutive local recurrences, and six pulmonary metastases, obtained at two different occasions, of a malignant fibrous histiocytoma (MFH). Simultaneous existence of more than one cytogenetically aberrant clone was also assessed through analysis of more than one sample from the same surgical specimen. Clonal chromosome aberrations were detected in all samples from the synovial sarcoma, and in both local recurrences and five of the metastases from the MFH. All clones in both tumors were cytogenetically related. The primary synovial sarcoma tumor contained two clones, one of which was also found in the lung metastases, together with a third clone that had acquired additional aberrations. Four clones with a near-tetraploid chromosome number and complex aberrations were identified in the MFH. Likely evolutionary pathways could be deduced in both cases. In the patient with synovial sarcoma one of the pulmonary metastases, rather than the primary tumor, might well have been the source of another of the pulmonary metastases. In the MFH the cytogenetic findings indicated the presence of two co-existing lineages in the primary tumor, one giving rise to the local recurrences and one to the pulmonary metastases. Our findings show that cytogenetic analysis can be used to establish the chronologic relationships between different clones in primary tumors, local recurrences and distant metastases, to determine what genetic changes are of importance for the metastatic capability of tumor cells, and to help establish the origin of the metastatic lesions.
Similar content being viewed by others
References
Nowell PC, 1989, The clonal nature of neoplasia. Cancer Cells, 1, 29–30.
Nowell PC, 1989, Chromosomal and molecular clues to tumor progression. Seminars in Oncology, 16, 116–127.
Weinberg RA, 1989, Oncogenes, antioncogenes, and the molecular basis of multistep carcinogenesis. Cancer Research, 49, 3713–3721.
Heim S, Mitelman F and Mandahl N, 1988, Genetic convergence and divergence in tumor progression. Cancer Research, 48, 5911–5916.
Fidler IJ and Hart IR, 1982, Biological diversity in metastatic neoplasms: origin and implications. Science, 217, 998–1003.
Nicholson GL, 1991, Gene expression, cellular diversification and tumor progression to the metastatic phenotype. BioEssays, 13, 337–342.
Heim S and Mitelman F. Cancer Cytogenetics. New York: Alan R. Liss, 1987.
Heim S and Mitelman F, 1992, Cytogenetics of solid tumors. Recent Advances in Histopathology, 15, 37–66.
Mitelman F. Catalog of Chromosome Aberrations in Cancer, 4th edn. New York: Wiley-Liss, 1991.
Örndal C, Mandahl N, Rydholm A, Nilbert M, Heim S, Åkerman M and Mitelman F, 1990, Chromosomal evolution and tumor progression in a myxoid liposarcoma. Acta Orthopaedica Scandinavica, 61, 99–105.
Örndal C, Mandahl N, Rydholm A, Willén H, Brosjö O and Mitelman F, 1992, Chromosome aberrations and cytogenetic intratumor heterogeneity in chondrosarcomas Journal of Cancer Research and Clinical Oncology, in press.
Örndal C, Mandahl N, Rydholm A, Willén H, Carlén B, Heim S and Mitelman F, 1992, Cytogenetic heterogeneity and clonal evolution in a re current fibrosarcoma. Journal of Experimental and Clinical Cancer Research, 12, 23–31.
Mandahl N, Heim S, Arheden K, Rydholm A, Willén H and Mitelman F, 1988, Three major cytogenetic subgroups can be identified among chromosomally abnormal solitary lipomas. Human Genetics, 79, 203–208.
ISCN, 1991, In: Mitelman F, ed. Guidelines for Cancer Cytogenetics, Supplement to an International System for Human Cytogenetic Nomenclature, Basel: S. Karger, 1991.
Fletcher JA, Kozakewich HP, Hoffer FA, Lage JL, Weidner N, Tepper R, Pinkus GS, Morton CC and Corson JM, 1991, Diagnostic relevance of clonal cytogenetic aberrations in malignant soft-tissue tumors. New England Journal of Medicine, 324, 436–442.
Enzinger FM and Weiss SW. Soft Tissue Tumors, 2nd edn. St Louis: CV Mosby, 1988.
Mandahl N, Heim S, Willén H, Rydholm A, Eneroth M, Nilbert M, Kreicbergs A and Mitelman F, 1989, Characteristic karyotypic anomalies identify subtypes of malignant fibrous histiocytoma. Genes, Chromosome and Cancer, 1, 9–14.
Örndal C, Mandahl N, Rydholm A, Willén H, Brosjö O, Heim S and Mitelman F, 1992, Super-numerary ring chromosomes in five bone and soft tissue tumors of low or borderline malignancy. Cancer Genetics and Cytogenetics, 60, 170–175.
Rydholm A, Mandahl N, Heim S, Kreicbergs A, Willén H and Mitelman F, 1990, Malignant fibrous histiocytomas with a 19p+ marker chromosome have increased relapse rate. Genes, Chromosomes and Cancer, 2, 296–299.
Liotta LA and Stetler-Stevenson WG. Principles of molecular cell biology of cancer: cancer metastasis. In: De Vita VT Jr, Hellman S and Rosenberg SA, eds. Cancer Principles & Practice of Oncology, 3rd edn, pp. 98–115. Philadelphia: Lippincott, 1989.
Schirrmacher V, 1985, Cancer metastasis: experimental approaches, theoretical concepts, and impacts for treatment strategies. Advances in Cancer Research, 43, 1–73.
Alexander P. The biology of metastases. In: Carney D and Sikora K, eds. Genes and Cancer, pp. 313–328. Chichester: John Wiley, 1990.
Barr LC, Stotter AT and A'Hern RP, 1991, Influence of local recurrence on survival: a controversy reviewed from the perspective of soft tissue sarcoma. British Journal of Surgery, 78, 648–650.
Gustafson P, Rööser B and Rydholm A, 1991, Is local recurrence of minor importance for metastases in soft tissue sarcoma? Cancer, 67, 2083–2086.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Örndal, C., Mandahl, N., Willén, H. et al. Cytogenetic evolution in primary tumors, local recurrences, and pulmonary metastases of two soft tissue sarcomas. Clin Exp Metast 11, 401–408 (1993). https://doi.org/10.1007/BF00132983
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00132983